TGF-β, another anti-inflammatory cytokine, was found to be significantly reduced in T1D patients, whereas IL-17 and IL-23 levels remained unchanged in some studies, further highlighting TGF-β’s possible protective function [134]. The gene discussed is IL17A; the disease is type 1 diabetes mellitus.